Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma Cells
- 27 August 1987
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 317 (9), 526-532
- https://doi.org/10.1056/nejm198708273170902
Abstract
Myeloma cells destroy bone by producing an osteoclast-stimulating factor that has chemical and biological characteristics similar to the bone-resorbing activity present in the supernatants of activated leukocyte cultures. Recently, a number of bone-resorbing leukocyte cytokines have been identified, including interleukin-1, lymphotoxin, and tumor necrosis factor. We have examined the products of human myeloma cells for the presence of these bone-resorbing cytokines.This publication has 38 references indexed in Scilit:
- Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gammaJournal of Bone and Mineral Research, 1986
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activityNature, 1984
- Cloning and expression of murine interleukin-1 cDNA in Escherichia coliNature, 1984
- Failure of parathyroid hormone antagonists to inhibit in vitro bone resorbing activity produced by two animal models of the humoral hypercalcemia of malignancy.Journal of Clinical Investigation, 1984
- The Hypercalcemia of CancerNew England Journal of Medicine, 1984
- An interleukin 1 like factor stimulates bone resorption in vitroNature, 1983
- A Parathyroid Hormone Inhibitor in Vivo: Design and Biological Evaluation of a Hormone AnalogScience, 1983
- Distribution of Surface, Cytoplasmic and Secreted IgG Subclasses in Human Lymphoblastoid Cell Lines and Normal Peripheral Blood LymphocytesScandinavian Journal of Immunology, 1981
- Relative importance of renal failure and increased bone resorption in the hypercalcaemia of myelomatosis.Journal of Clinical Pathology, 1981